Table 1.
Immune model | ||
---|---|---|
Ref | Favourable | Unfavourable |
14 | NK like T-cells | NK-cells |
13 | NI |
PD-1+CD8+ T-cells, CD28−CD57+CD8+ T-cells |
22 |
Resting mast cells, CD8+ T-cells, M2 macrophages, Follicular helper T-cells |
Activated NK-cells, Naïve B-cells |
23 | CTLA4−LAG3− T-helper cells |
M1 polarised macrophages, FOXP3+ helper T-cells, Tregs |
15 | NI | Eomes+ T-betlow CD8+ T-cells |
16 | NI | CD4+ CD25+ CD127low Treg |
17 | NI | ICOS+ Tregs |
20 | NI |
PD-1, PD-L1, PD-L2, Co-expression of PD-1/CTLA-4, Co-expression of PD-L2/CTLA-4 |
21 | NI | PVR, PVRL2 |
Metabolic model | ||
32 | Citrate |
Lactate, 2-Oxoglutarate, Pyruvate, 2-Hydroxyglutarate, Glycerol-3-phosphate |
33 |
Lysine, Methionine |
NI |
36 | CYP2E1, HAAO, ITPKA, PAFAH1B2 | ALDH2, DNMT3B, ENPP2, PHGDH, PSAT1 |
35 | NI | PLA2G4A, HMOX2, AK1, SMPD3 |